1 2 "Mounjaro tirzepatide 15 mg/0.5 mL solution for injection pre-filled pen (379334)"
However, concerns about Ozempic vision loss problems began to emerge in July 2024, following the publication of a study by Harvard researchers who found that patients using semaglutide may face a seven-fold increased risk for experiencing sudden vision changes, blurred sight, blindness or other symptoms linked to NAION, a rare condition where the optic nerve suffers from insufficient blood flow
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if you also have a weight related condition such as type 2 diabetes, high blood pressure, or raised cholesterol
Here is how the available evidence compares across medications
Cold intolerance
Yes, clinical data shows that subjects taking the formula exhibited a 12.45-fold increase in plasma GLP-1 levels relative to baseline at 90 minutes post-ingestion